Compass Pathways plc - ADR (5Y6)
Munich
Closed
Aug 27, 2026
Day's Range
12.6052 wk Range
3.80Overview - 5Y6 - Compass Pathways plc - ADR
Key Statistics
Valuation
Enterprise Value
-114.57M
P/E (Trailing)
‪-4.09‬
PEG Ratio
‪-0.01‬
Price / Book
‪20.12‬
EV / EBITDA
‪0.68‬
Profitability
Return on Assets
‪-136.84%‬
Return on Equity
‪544.69%‬
Ownership
Shares Outstanding
134.94M
Price stats
50-Day Avg
‪11.26‬
200-Day Avg
‪7.76‬
Peers - 5Y6 - Compass Pathways plc - ADR
Peer Comparison
Compared with companies in Medical Care Facilities listed on Munich.
- 5Y6MunichCompass Pathways plc Depositary Receipt+67.46%52-week change-4.09P/E (Trailing)—Profit Margin
- HTWMunichNational HealthCare Corporation+50.51%52-week change25.59P/E (Trailing)‪8.99%‬Profit Margin
- EIFMunichMednation AG+58.49%52-week change3.96P/E (Trailing)‪87.85%‬Profit Margin
- 5XEMunichExtendicare Inc.+57.73%52-week change17.14P/E (Trailing)—Profit Margin
- 7ATMunichAttendo AB (publ)+44.45%52-week change1.97P/E (Trailing)‪45.31%‬Profit Margin
- HCQMunichAmn Healthcare Services Inc.+42.33%52-week change-12.10P/E (Trailing)‪28.34%‬Profit Margin
- 1ZUMunichThe Pennant Group, Inc.+36.59%52-week change38.14P/E (Trailing)‪13.77%‬Profit Margin
Profile Summary - 5Y6 - Compass Pathways plc - ADR
About
Compass Pathways plc Depositary Receipt represents shares in Compass Pathways plc, a biotechnology company focused on mental health innovation in the United Kingdom and the United States. The company develops COMP360, a proprietary investigational formulation of synthetic psilocybin therapy administered with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
